Semaglutide and B12: the benefits, the evidence, and what to expect

Step 1: what semaglutide is actually doing in your body

Semaglutide binds to GLP-1 receptors in the gut and brain, prompting the pancreas to release insulin in response to food, slowing how quickly the stomach empties and, crucially, dampening the appetite signals that drive overeating. The result is that many people find it considerably easier to eat smaller portions without the persistent hunger that usually follows calorie reduction. The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, alongside a reduced-calorie diet and increased activity — a meaningful result by any clinical standard.

This appetite-lowering effect is central to the B12 question. When food intake falls significantly, so does the variety and volume of nutrients arriving through diet. B12 is found almost exclusively in animal-derived foods (meat, fish, eggs, dairy) and people who were already eating modestly, following plant-based diets, or are over 60 (where absorption naturally declines) can be closer to deficiency before treatment starts. A substantial reduction in eating amplifies that risk. You can explore the broader clinical benefits of semaglutide in more detail if you want the wider picture beyond weight.

Step 2: where B12 becomes relevant during treatment

Vitamin B12 deficiency is not a listed side effect of semaglutide in the Wegovy SmPC, and the drug itself does not deplete B12 through a direct pharmacological mechanism. The concern is indirect: reduced dietary intake, combined with possible changes in eating patterns (some people shift away from red meat and other rich B12 sources because those foods can worsen GI side effects on GLP-1 treatment), can push borderline B12 levels lower over time.

Symptoms of B12 insufficiency include unusual tiredness, pins and needles in the hands or feet, difficulty concentrating and low mood. Some of those overlap with the fatigue that can accompany the early weeks of semaglutide treatment, making them easy to dismiss. A simple blood test can distinguish the two. If your GP or prescriber identifies low or borderline B12, supplementation is straightforward, oral tablets are widely available, and intramuscular injections are used for more significant deficiency. The weight-loss-specific benefits of semaglutide are well-documented; whether B12 supplementation alongside it improves outcomes beyond correcting deficiency is a different question, and one the current trial evidence does not clearly answer.

People who are vegetarian, vegan, over 50, or who have had gastrointestinal surgery may be at higher baseline risk and worth screening before treatment starts. Discussing this with a prescriber before your first pen arrives is a better approach than self-supplementing in response to a vague sense of tiredness.

Step 3: sorting fact from marketing around "semaglutide B12 injections"

Online, you will sometimes see semaglutide advertised alongside B12 as a combined injection, often marketed as a weight-loss booster. There is an important clinical and legal point here. In the UK, Wegovy is the licensed semaglutide product for weight management; it is a prescription-only medicine, and the only route to it legally is through a prescriber following a proper clinical assessment, as the NHS patient information for semaglutide makes clear. Compounded or unlicensed "semaglutide plus B12" injections from unverified sellers carry real risks: dosing accuracy, sterility and authenticity cannot be guaranteed, and the MHRA has warned repeatedly about counterfeit and unlicensed GLP-1 products circulating in the UK.

B12 has a well-established safety profile at standard doses and can be a reasonable adjunct when there is a clinical reason. It is not, on the current evidence, a performance enhancer for semaglutide's weight-loss action. Claims that pairing the two dramatically amplifies results are not supported by published clinical data. If you are weighing up different aspects of semaglutide's therapeutic profile, the honest answer is that the medicine's proven effects come from semaglutide itself, not from co-administration of vitamins.

Step 4: what a proper clinical review covers before you start

A thorough pre-treatment assessment is where the B12 question gets a proper answer for you as an individual. A GPhC-registered prescriber can review your dietary habits, any existing blood results, your medical history and any medications, and advise whether baseline B12 monitoring makes sense in your case. Women in particular may have additional nutritional considerations worth factoring in, especially around hormonal health and bone density during significant weight change.

At nume, every consultation is read personally by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) on the same day you submit it. If approved, treatment is dispatched the same day for free next-working-day delivery by DPD, arriving in plain, unbranded packaging that gives nothing away. The pen itself is exactly what Eli Lilly manufactures and ships through the licensed UK supply chain. For questions about how pricing works across a full course of treatment, the treatment options page sets out what is included transparently, with no hidden fees. For more on what the clinical evidence says about semaglutide overall, the full breakdown of taking semaglutide covers the STEP programme data in depth.

If you are already on semaglutide and have questions, or are wondering whether Wegovy might be suitable for you, speaking to a prescriber is the sensible next step. Our team is available seven days a week for aftercare questions, and an initial consultation is free.